FTC Says Shkreli Has No Good Reason To Delay Antitrust Trial

By Nadia Dreid (October 18, 2021, 6:29 PM EDT) -- The Federal Trade Commission is fighting back against disgraced former pharmaceutical executive Martin Shkreli's bid to have his mid-December civil trial pushed back to May, telling a New York federal judge that it is simply the latest in a line of attempts to delay trial.

The agency's response to Shkreli's motion came Friday, two days after he asked U.S. District Judge Denise Cote to bump his rapidly approaching trial date up by almost five months.

Shkreli says the current timeline of the case would put in jeopardy an opportunity for early release from the federal prison where he's serving a seven-year...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!